COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R): Presentation of New Data on MDxHealth's Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting

22/05/2018 - 07:01

NEWS RELEASE Moderated posters and oral presentations feature clinical and health economic validations of SelectMDx, ConfirmMDx and prospective clinical validation of AssureMDx IRVINE, CA, and HERSTAL, BELGIUM - 07.00 [...]

MDxHealth (R) :

22/05/2018 - 07:01

Verona Pharma Presented Clinical Data at ATS 2018 that Further Highlights RPL554 as a First-in-Class Treatment for COPD

21/05/2018 - 23:15

Achieved statistically significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action in COPD patients with RPL554 when added to tiotropium LONDON, May 21, 2018 (GLOBE [...]

Trevena Appoints Mark A. Demitrack, M.D., as Chief Medical Officer

21/05/2018 - 23:13

CHESTERBROOK, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced the appointment of Mark Demitrack, M.D., as Senior Vice President and Chief Medical Officer. Dr. Demitrack brings over 20 [...]

Columbus Regional Healthcare System Selects Cerner Integrated EHR to Support Improved Patient Care

21/05/2018 - 22:31

WHITEVILLE, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Columbus Regional Healthcare System (CRHS) has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) [...]

Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders

21/05/2018 - 22:30

Board of Directors Recommends Removal of Terminated CEO Joseph Payne from Board of Directors SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Arcturus or the Company) (NASDAQ: ARCT ), an RNA [...]

Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential Diagnostics List

21/05/2018 - 22:15

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 21, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that the Company’s T-SPOT. TB test [...]

The Cooper Companies to Present at Goldman Sachs Healthcare Conference

21/05/2018 - 22:15

PLEASANTON, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) will present at the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, CA, on June 14, 2018. Daniel G. McBride, Esq, [...]

Globus Medical Announces Appointment of Orthopedic Trauma Division’s Vice President of Sales

21/05/2018 - 22:15

AUDUBON, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the [...]

Coherus Announces Proposed Public Offering of Common Stock

21/05/2018 - 22:15

REDWOOD CITY, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. All of the [...]

Syneos Health to Present at Upcoming Investors Conferences

21/05/2018 - 22:15

RALEIGH, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract [...]

Melinta Therapeutics Announces Proposed Offering of Common Stock

21/05/2018 - 22:10

NEW HAVEN, Conn., May 21, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

MyoKardia Announces Proposed Public Offering of Common Stock

21/05/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2018

21/05/2018 - 22:00

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a biopharmaceutical company, today announced that updated results from the company’s randomized, double-blind, placebo-controlled Phase 2b [...]

Sanofi: New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma

21/05/2018 - 20:16

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent ® (dupilumab) improved moderate-to-severe asthma Results showed Dupixent [...]

Sanofi : Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent® (dupilumab) améliore l'asthme modéré à sévère

21/05/2018 - 20:16

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent ® (dupilumab) améliore l' [...]

UroGen Pharma Announces Positive Interim Results from Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)

21/05/2018 - 19:40

Interim Results Showed Complete Response (CR) Rate of 59 Percent in Patients with Low-Grade UTUC CRs to Date Remain Durable at Three, Six and Nine-Month Follow-Up RA’ANANA, Israel and NEW YORK, May 21, 2018 (GLOBE [...]

Dova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag)

21/05/2018 - 18:43

Company to Host Conference Call at 4:30 pm DURHAM, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced the U.S. Food and Drug Administration (FDA) has completed their [...]

Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs

21/05/2018 - 18:16

INDIANAPOLIS, May 21, 2018 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs [...]